Erwin Ott
University of Graz
45 Papers
257 Citations
Erwin Ott is an academic researcher from University of Graz. The author has contributed to research in topics: Medicine & Parkinsonism. The author has an hindex of 16, co-authored 45 publications. Previous affiliations of Erwin Ott include Medical University of Graz.
Chat about Author
Papers
Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
Elisabeth Wolf,Klaus Seppi,Regina Katzenschlager,Guenter Hochschorner,Gerhard Ransmayr,Petra Schwingenschuh,Erwin Ott,Iris Kloiber,Dietrich Haubenberger,Eduard Auff,Werner Poewe +10 more
TL;DR: Findings argue for long‐term antidyskinetic efficacy of amantadine in PD patients with LID's.
205
Sleep attacks in patients taking dopamine agonists: review
Carl Nikolaus Homann,Karoline Wenzel,K. Suppan,Gerd Ivanic,Norbert Kriechbaum,Richard Crevenna,Erwin Ott +6 more
TL;DR: Insufficient data is available to provide effective guidelines for prevention and treatment of sleep events in patients taking dopamine agonists for Parkinson's disease, and Prospective population based studies are needed to provide this information.
149
Efficacy and Safety of Radiosurgical Callosotomy: A Retrospective Analysis
Michael Feichtinger,O. Schröttner,Hans G. Eder,Hans Holthausen,Tom Pieper,F. Unger,Alexander Holl,Lucia Gruber,E. Körner,Eugen Trinka,Franz Fazekas,Erwin Ott +11 more
TL;DR: Anterior callosotomy is a surgical option for the treatment of generalized tonic or atonic seizures associated with drop attacks, but reliable data about tolerability and efficacy are sparse.
58
The Bradykinesia Akinesia Incoordination Test (BRAIN TEST), an objective and user-friendly means to evaluate patients with parkinsonism.
JD Carl Nikolaus Homann Md,K. Suppan,Karoline Wenzel,Gavin Giovannoni,Gert Ivanic,S. Horner,Erwin Ott,Hans-Peter Hartung +7 more
TL;DR: A significant correlation between the four test parameters and PD rating scores of the Hoehn & Yahr, Schwab & England, and Unified PD Rating Scales is found among parkinsonian patients.
57
Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease.
Alexander Zimprich,Friedrich Asmus,Petra Leitner,Mirna Castro,Benjamin Bereznai,Nikolaus Homann,Erwin Ott,A. Wijnand F. Rutgers,Gyri Wieditz,Claudia Trenkwalder,Thomas Gasser +10 more
TL;DR: The findings show that sequence alterations in exon 1 of the NR4A2 gene are not a major cause of familial PD in central Europe, and no mutations were found in the 30 families with known parent-child transmission.
40